A former CEO and director of InVentiv Health, Terrell (Terry) Herring assumed the role of president of Mission Pharmacal Company in 2010. The following year, Terrell Herring also began serving as president of Alamo Pharma Services, a recruitment and talent acquisition company specializing in the pharmaceutical and biotech sector.
In February 2017, Alamo announced a partnership with Napo Pharmaceuticals, Inc., to create a national sales team for the company's new FDA-approved drug Mytesi, which provides relief from noninfectious diarrhea in people with HIV who are on antiretroviral therapies. Napo Pharmaceuticals and its partner company, Jaguar Animal Health, Inc., estimate a potential U.S. market value of more than $100 million in annual sales for the drug, and Alamo will significantly help them reach that target. Mytesi's active pharmaceutical ingredient is crofelemer, an anti-secretory agent harvested from the rain forest. The twice-daily tablets yielded encouraging results in clinical trials with HIV-positive patients, showing a reduction in the average number of watery stools per week from 20 to less than two.
0 Comments
A graduate of the Military College of South Carolina (the Citadel), Terrell “Terry” Herring is a successful pharmaceutical industry executive and entrepreneur. Currently, Terrell Herring applies his expertise as the president of Mission Pharmacal and Alamo Pharma Services, where he provides daily strategic leadership. Founded in 1946, Mission Pharmacal is a privately held, San Antonio-based pharmaceutical company. Since its inception, the firm has actively delivered prescription and over-the-counter drugs and supplements to consumers to help improve their lives. Throughout its first seven decades, the company has grown and diversified to include seven firms known as the Mission Family of Companies. Among these are: - Alamo Pharma Services – an outsourced sales organization founded in 2011. - BioComp Pharma – a subsidiary that was founded in 2009 to focus on the commercialization of generic drugs. - Prosolus – a subsidiary acquired in 2015 that develops and manufactures transdermal and trans-mucosal drug delivery products - Espada Dermatology - a consumer dermatology division. - BexR Logistix – a third party logistics firm that serves multiple industries. - EPIC Fulfillment - a subsidiary of BexR and the warehousing arm of Mission. Terrell Herring is a business executive in the pharmaceutical sector, who often goes by Terry. Currently the president of Mission Pharmacal and Alamo Pharma Services, Terrell Herring also serves on the board of directors for Bridging the Gap Africa.
A nonprofit organization, Bridging the Gap Africa (BtGA) works to build footbridges across rivers in rural Kenya to improve the lives of local community residents. The bridges allow residents to safely access necessary social services, healthcare, education, and economic opportunity. A single bridge allows approximately 200 safe crossings a day, which adds up to 72,800 safe crossings annually. The bridge building process at BtGA begins with a request for assistance from a community in Kenya. BtGA then engages volunteers and members of that local community who are active in every step of the actual build. During this process, technical assistance and financing is also provided by BtGA to ensure the project's success. Once a bridge is completed, a ceremony is held to celebrate the completed project and fully transfer ownership of the bridge to the local community. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|